Lucid Capital Markets analyst Alex Nowak initiates coverage on Prenetics (NASDAQ: PRE) with a Buy rating and a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage